Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Non-comparative Extension of Study AC-058B301, to Investigate the Long-term Safety, Tolerability, and Control of Disease of Ponesimod 20 mg in Subjects With Relapsing Multiple Sclerosis

NCT03232073 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT03232073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Non-comparative Extension of Study AC-058B301, to Investigate the Long-term Safety, Tolerability, and Control of Disease of Ponesimod 20 mg in Subjects With Relapsing Multiple Sclerosis
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
July 5, 2017
Completion date
January 16, 2024
Enrollment
877 (actual)
Sites
148

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis